BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Activity
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

31 hedge funds and large institutions have $69.4M invested in Bellerophon Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
31
Holders Change
+5
Holders Change %
+19.23%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
5
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.04M
2
TI
2
Telemetry Investments
New York
$414K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$2.15M
4
DS
4
DRW Securities
Illinois
$146K
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$47K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.35M
2
VF
2
Virtu Financial
New York
$0
3
OAM
3
Oxford Asset Management
United Kingdom
$0
4
Bank of America
4
Bank of America
North Carolina
$2K
5
EI
5
EAM Investors
California
$483K
Name Market Value Shares Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$12K 373 +373 New
IA
27
IFP Advisors
Florida
$3K 67 – –
FDCDDQ
28
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.08K 67 – –
Bank of America
29
Bank of America
North Carolina
$2K 74 -990 -93%
Morgan Stanley
30
Morgan Stanley
New York
$1K 33 – –
VF
31
Virtu Financial
New York
– – -3,771 Closed
OAM
32
Oxford Asset Management
United Kingdom
– – -2,023 Closed
AG
33
Advisor Group
Arizona
– – -18 Closed
Barclays
34
Barclays
United Kingdom
$0 4 +4 New
1
2